Brief: Spago Nanomedical Signs Agreement For Conduct Of Clinical Study With SpagoPix

Spago Nanomedical AB (publ)

28/05/2018 08:08

May 28 (Reuters) - SPAGO NANOMEDICAL AB (PUBL)  SPAGO.TE :
    * SPAGO NANOMEDICAL SELECT CTC FOR THE FIRST CLINICAL TRIAL
WITH
SPAGOPIX
    * AIM OF CLINICAL TRIAL IS TO DOCUMENT SAFETY AND MR IMAGES
IN
CANCER PATIENTS
    * SIGNED AN AGREEMENT WITH CRO CTC CLINICAL TRIAL
CONSULTANTS AB
FOR CONDUCT OF CLINICAL STUDY WITH SPAGOPIX.

Source text for Eikon:  ID:nWkr8LnnL4 
Further company coverage:  SPAGO.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))